Eculizumab for the treatment of two recurrences of atypical hemolytic uremic syndrome in a kidney allograft
- PMID: 22591029
- DOI: 10.1111/j.1432-2277.2012.01497.x
Eculizumab for the treatment of two recurrences of atypical hemolytic uremic syndrome in a kidney allograft
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
